Capstone Holding announced the closing of its previously announced acquisition of Carolina Stone Products ahead of schedule. Transaction Highlights: Closing Date: August 22, 2025; Target: Carolina Stone Products; Financials: Revenue $11 million; LTM EBITDA $0.75 million/ 2026 1.001 million; Purchase Price & Multiple: $3.9-$4.7 million; Accretion: Immediately accretive to revenue and EBITDA at close; Strategic fit: Expands Southeast footprint; adds premium brands; supports margin expansion. “With Friday’s closing, we’re delivering exactly what we said we would: immediately accretive acquisitions at disciplined valuations,” said Matthew Lipman, CEO. “Carolina Stone strengthens our brand portfolio, gives us a foothold in one of the nation’s fastest-growing construction markets, and positions us for a ~$100 million revenue run-rate entering 2026.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPS:
- Capstone enters agreement to acquire Carolina Stone Products
- Capstone Therapeutics Acquires Carolina Stone Holdings
- Capstone Holding Corp. Reports Q2 2025 Earnings and Restructuring
- Capstone Holding targets $100M revenue run-rate by year-end or Q1
- Capstone Therapeutics Adjusts Convertible Note Conversion Price